RVL Pharmaceuticals
RVLP
#10268
Rank
NZ$5.47 M
Marketcap
$0.04911
Share price
-32.05%
Change (1 day)
N/A
Change (1 year)

EPS for RVL Pharmaceuticals (RVLP)

EPS in 2023 (TTM): -$1.15

According to RVL Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.22. In 2022 the company made an earnings per share (EPS) of -$0.98 an increase over its 2021 EPS that were of -$1.65.

EPS history for RVL Pharmaceuticals from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.1517.83%
2022-$0.98-41.05%
2021-$1.65-26.36%
2020-$2.25-75.05%
2019-$9.00146.15%
2018-$3.66